From the McGill (Que.) Daily:
Six months after Industry Canada finished its review of legislation that allows Canadian drug manufacturers to produce and export generic medicines, a report of the findings has yet to be completed.
The legislation, known as the Canada Access to Medicines Regime (CAMR), was passed in 2004 to facilitate access to affordable essential medicines in developing countries. But the legislation is widely recognized as flawed – so far, not a single pill has left the country. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment